2022
Epidemiology and outcomes of surgical site infections among pediatric liver transplant recipients
Banach DB, Lopez‐Verdugo F, Sanchez‐Garcia J, Tran A, Gomez‐Llerena A, Munoz‐Abraham A, Bertacco A, Valentino PL, Yoo P, Dembry L, Mulligan DC, Ekong UD, Emre SH, Rodriguez‐Davalos M. Epidemiology and outcomes of surgical site infections among pediatric liver transplant recipients. Transplant Infectious Disease 2022, 24: e13941. PMID: 35989545, DOI: 10.1111/tid.13941.Peer-Reviewed Original ResearchConceptsSurgical site infectionLiver transplant recipientsLiver transplantationBiliary complicationsGraft recipientsTransplant recipientsSite infectionRisk factorsOutcomes of SSIPediatric liver transplant recipientsLong-term graftPediatric liver transplantationRetrospective descriptive analysisPrimary endpointHospital daysPatient agePediatric populationPatient survivalSignificant causeComplicationsPatientsRecipientsOutcomesInfectionIncidence
2011
Indeterminate QuantiFERON® -TB Gold results in a public health clinic setting
Banach DB, Harris TG. Indeterminate QuantiFERON® -TB Gold results in a public health clinic setting. The International Journal Of Tuberculosis And Lung Disease 2011, 15: 1623-1630. PMID: 22118169, DOI: 10.5588/ijtld.11.0017.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAdultAge FactorsAgedAmbulatory Care FacilitiesChildCross-Sectional StudiesFemaleFollow-Up StudiesHumansInterferon-gamma Release TestsLatent TuberculosisLogistic ModelsMaleMiddle AgedMultivariate AnalysisMycobacterium tuberculosisNew York CityPublic HealthRacial GroupsRetrospective StudiesSex FactorsTuberculosisYoung AdultConceptsIndeterminate resultsIndeterminate QFT-G resultsMultivariate logistic regression analysisQFT-G resultsLogistic regression analysisRace/ethnicityChest clinicPatient characteristicsTB GoldClinic settingQuantiFERONFurther studiesPatientsRegression analysisModest proportionHispanicsNew York CityClinicYork City